News

Published on 8 Nov 2021 on Insider Monkey via Yahoo Finance

Were Hedge Funds Right About RH (RH)?


Article preview image

In this article you are going to find out whether hedge funds think RH (NYSE:RH) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting for known risk attributes. It's not surprising given that hedge funds have access to better information and more resources to predict the winners in the stock market.

Is RH (NYSE:RH) worth your attention right now? The smart money was taking a bullish view. The number of long hedge fund positions rose by 4 in recent months. RH (NYSE:RH) was in 54 hedge funds' portfolios at the end of June. The all time high for this statistic was previously 50. This means the bullish number of hedge fund positions in this stock currently sits at its all time high. Our calculations also showed that RH isn't among the 30 most popular stocks among hedge funds (click for Q2 rankings). There were 50 hedge funds in our database with RH positions at the end of the first quarter.

To the average investor there are several indicators shareholders use to evaluate publicly traded companies. A couple of the best indicators are hedge fund and insider trading activity. Our researchers have shown that, historically, those who follow the top picks of the best fund managers can outpace their index-focused peers by a very impressive amount (see the details here). Also, our monthly newsletter's portfolio of long stock picks returned 185.4% since March 2017 (through August 2021) and beat the S&P 500 Index by more than 79 percentage points. You can download a sample issue of this newsletter on our website.

NYSE.CNP price evolution
NYSE.WRK price evolution
NYSE.RH price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio

Abiomed, Inc. ABMD is well-poised for growth in the coming quarters, backed by strength in its...

MSN News 27 Dec 2022

3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio

Abiomed, Inc. ABMD is well-poised for growth in the coming quarters, backed by strength in its Im...

Zacks via Yahoo Finance 22 Dec 2022

A Look At Abiomed Before The $380/Share Buyout From JNJ (ABMD)

Since our last publication on Abiomed, Inc. (NASDAQ:ABMD) where we had a buy thesis fully intact,...

Seeking Alpha 22 Dec 2022

Abiomed Inc. stock rises Wednesday, still underperforms market

Shares of Abiomed Inc. inched 0.06% higher to $381.02 Wednesday, on what proved to be an all-arou...

Market Watch 22 Dec 2022

Abiomed Inc. stock underperforms Monday when compared to competitors despite daily gains

Shares of Abiomed Inc. inched 0.08% higher to $381.30 Monday, on what proved to be an all-around ...

Market Watch 20 Dec 2022

The 3 Safest Stocks to Buy in the Market Now

Along with an interest rate hike of 50 bps at the FOMC meeting last week, the Fed officials signa...

Entrpreneur 19 Dec 2022

3 Stocks to Buy That Could Make You a Millionaire in the Long Term

Given an uncertain market backdrop, investors should buy fundamentally sound and dividend-paying...

Entrpreneur 16 Dec 2022

Abiomed Inc. stock falls Monday, underperforms market

Shares of Abiomed Inc. slid 0.19% to $380.01 Monday, on what proved to be an all-around positive ...

Market Watch 12 Dec 2022

Amgen Agrees to Acquire Horizon Therapeutics for $27.8 Billion

The U.S. biotech company’s deal for the drugmaker, which develops medicines to treat autoimmune a...

The Wall Street Journal 12 Dec 2022

4 Stocks That Can Weather Any Market Storm

Given the uncertain market backdrop, it could be wise to invest in fundamentally sound and resili...

Entrpreneur 9 Dec 2022